clinical pharmacology
Last reviewed 01/2018
- stabilises neuronal membranes and reduces the release of excitatory amino acids, especially glutamate, by blocking voltage-sensitive sodium channels
- rapid and complete absorption after oral administration
- metabolised in the liver, largely by glucorinidation, and has an elmination half-life of 25-30 hours
- about 55% protein-binding